It is very uncertain whether mepolizumab 10 mg/kg changes histological improvement at 12 weeks (dichotomous) compared with mepolizumab 0.55 mg/kg (very low certainty).
It is very uncertain whether mepolizumab 2.5 mg/kg changes histological improvement at 12 weeks (dichotomous) compared with mepolizumab 0.55 mg/kg (very low certainty).
It is very uncertain whether mepolizumab 10 mg/kg changes histological improvement at 12 weeks (dichotomous) compared with mepolizumab 2.5 mg/kg (very low certainty).
It is very uncertain whether swallowed fluticasone changes histological improvement at 4 weeks (dichotomous) compared with oral prednisone (very low certainty).
It is very uncertain whether esomeprazole changes histological improvement at 8 weeks (dichotomous) compared with fluticasone (very low certainty).
It is very uncertain whether one‐food elimination diet changes histological improvement at 12 weeks (dichotomous) compared with four‐food elimination diet (very low certainty).
It is very uncertain whether one‐food elimination diet changes histological improvement at 6 weeks (dichotomous) compared with six‐food elimination diet (very low certainty).
It is very uncertain whether four‐food elimination diet with omeprazole changes histological improvement at 8 to 12 weeks (dichotomous) compared with omeprazole (very low certainty).
It is very uncertain whether four‐food elimination and amino acid formula changes histological improvement at 6 weeks (dichotomous) compared with four‐food elimination diet (very low certainty).
The review found no eligible studies for this question.